Citius Pharmaceuticals Inc (NASDAQ:CTXR)
| 1.17 Delayed Data As of Aug 12 |  -0.02 / -1.68%Today’s Change | 0.83 Today|||52-Week Range 2.35 | -24.35% Year-to-Date |
Latest CTXR News | Press Releases
No recent news for Citius Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.19 |
| Today’s open | 1.13 |
| Day’s range | 1.08 - 1.22 |
| Volume | 1,102,740 |
| Average volume (3 months) | 1,623,285 |
| Market cap | $131.5M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | +49.64% |
| Earnings growth (this year) | +2.90% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLLSCellectis SA | +0.04 | +1.06% |
| SCPHscPharmaceuticals In... | +0.27 | +4.59% |
| TRVITrevi Therapeutics I... | -0.16 | -3.75% |
| VRCAVerrica Pharmaceutic... | +0.41 | +11.29% |
Data as of 3:59pm ET, 08/12/2022
Financials
| Last reporting date | August 12, 2022 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$23.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cranford, New Jersey |
Forecasts
